As of 2026-09-21, the Intrinsic Value of Solid Biosciences Inc (SLDB) is -10.52 USD. This SLDB valuation is based on the model Peter Lynch Fair Value. With the current market price of 8.91 USD, the upside of Solid Biosciences Inc is -218.05%.
Based on its market price of 8.91 USD and our intrinsic valuation, Solid Biosciences Inc (SLDB) is overvalued by 218.05%.
Note: result may not be accurate due to the invalid valuation result of Peter Lynch's fair value model.
| Range | Selected | Upside | |
| a | |||
| Fair Value | -10.52 - -10.52 | -10.52 | -218.05% |
| P/E | (39.97) - (50.07) | (43.33) | -586.4% |
| DDM - Stable | (12.90) - (33.20) | (23.05) | -358.7% |
| DDM - Multi | (0.37) - (0.73) | (0.49) | -105.5% |
| Market Cap (mil) | 877.19 |
| Beta | 1.06 |
| Outstanding shares (mil) | 98.45 |
| Enterprise Value (mil) | 717.80 |
| Market risk premium | 4.60% |
| Cost of Equity | 12.56% |
| Cost of Debt | 5.00% |
| WACC | 8.12% |